{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:31:29Z","timestamp":1792427489438,"version":"4.5.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.humimm.2020.04.002","type":"journal-article","created":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T00:58:24Z","timestamp":1587430704000},"page":"323-329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Development of de novo HLA donor specific antibodies (HLA-DSA), HLA antibodies (HLA-Ab) and allograft rejection post blood transfusion in kidney transplant recipients"],"prefix":"10.1016","volume":"81","author":[{"given":"M.","family":"Jalalonmuhali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.P.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Tsiopelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Clayton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.T.","family":"Coates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.humimm.2020.04.002_b0005","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/tri.12926","article-title":"Postoperative surgical-site hemorrhage after kidney transplantation: incidence, risk factors, and outcomes","volume":"30","author":"Hachem","year":"2017","journal-title":"Transpl. Int."},{"issue":"15","key":"10.1016\/j.humimm.2020.04.002_b0010","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJM197810122991503","article-title":"Improvement of kidney-graft survival with increased numbers of blood transfusions","volume":"299","author":"Opelz","year":"1978","journal-title":"N. Engl. J. Med."},{"issue":"7882","key":"10.1016\/j.humimm.2020.04.002_b0015","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0140-6736(74)93268-1","article-title":"Poor kidney-transplant survival in recipients with frozen-blood transfusions or no transfusions","volume":"2","author":"Opelz","year":"1974","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.humimm.2020.04.002_b0020","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00007890-198509000-00003","article-title":"Correlation of HLA matching with kidney graft survival in patients with or without cyclosporine treatment","volume":"40","author":"Opelz","year":"1985","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.humimm.2020.04.002_b0025","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1111\/j.1600-6143.2011.03705.x","article-title":"Blood transfusions in organ transplant patients: mechanisms of sensitization and implications for prevention","volume":"11","author":"Scornik","year":"2011","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2020.04.002_b0030","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/1471-2369-14-217","article-title":"An update on the impact of pre-transplant transfusions and allosensitization on time to renal transplant and on allograft survival","volume":"14","author":"Scornik","year":"2013","journal-title":"BMC Nephrol"},{"issue":"2","key":"10.1016\/j.humimm.2020.04.002_b0035","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1046\/j.1537-2995.1985.25285169200.x","article-title":"A randomized study comparing leukocyte-depleted versus packed red cell transfusions in prospective cadaver renal allograft recipients","volume":"25","author":"Sanfilippo","year":"1985","journal-title":"Transfusion"},{"issue":"12","key":"10.1016\/j.humimm.2020.04.002_b0040","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/00007890-199560120-00004","article-title":"Donor-specific transfusions have long-term beneficial effects for human renal allografts","volume":"60","author":"Flye","year":"1995","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.humimm.2020.04.002_b0045","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/00007890-199102000-00021","article-title":"Minimal sensitization and excellent renal allograft outcome following donor-specific blood transfusion with a short course of cyclosporine","volume":"51","author":"Cheigh","year":"1991","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.humimm.2020.04.002_b0050","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1111\/ajt.13795","article-title":"Impact of early blood transfusion after kidney transplantation on the incidence of donor-specific anti-HLA antibodies","volume":"16","author":"Ferrandiz","year":"2016","journal-title":"Am. J. Transplant."},{"issue":"1","key":"10.1016\/j.humimm.2020.04.002_b0055","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.humimm.2006.10.003","article-title":"HLAMatchmaker: A Molecularly Based Algorithm for Histocompatibility Determination. V. Eplet Matching for HLA-DR, HLA-DQ, and HLA-DP","volume":"68","author":"Duquesnoy","year":"2007","journal-title":"Hum. Immunol."},{"issue":"10","key":"10.1016\/j.humimm.2020.04.002_b0060","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1097\/TP.0b013e3181a44206","article-title":"Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts","volume":"87","author":"Lachmann","year":"2009","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.humimm.2020.04.002_b0065","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1097\/TP.0b013e3181a24b96","article-title":"Effects of Blood Transfusions Given After Renal Transplantation","volume":"87","author":"Scornik","year":"2009","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.humimm.2020.04.002_b0070","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s004670050791","article-title":"Pretransplant blood transfusions with cyclosporine in pediatric renal transplantation","volume":"14","author":"Niaudet","year":"2000","journal-title":"Pediatr. Nephrol."},{"issue":"1","key":"10.1016\/j.humimm.2020.04.002_b0075","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.trim.2013.09.008","article-title":"Peri-operative third party red blood cell transfusion in renal transplantation and the risk of antibody-mediated rejection and graft loss","volume":"29","author":"Fidler","year":"2013","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.humimm.2020.04.002_b0080","unstructured":"ANZDATA Registry. 42nd Report, C.A.T.W.L.A.a.N.Z.D.a.T.R., Adelaide, Australia. 2019. Available at: http:\/\/www.anzdata.org.au."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885920301294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885920301294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:52:48Z","timestamp":1759319568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885920301294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0198885920301294"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2020.04.002","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of de novo HLA donor specific antibodies (HLA-DSA), HLA antibodies (HLA-Ab) and allograft rejection post blood transfusion in kidney transplant recipients","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2020.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}